×
Search your requirement
Search your requirement
Home
Press Releases
Submit Release
Events
Reach Us
Social media
Search
Home
Press Releases
Submit Release
Events
Reach Us
Search
MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing
Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics
Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season
OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award
Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis
ProJenX announces the formation of its Clinical Advisory Board
Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma
NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients
Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits
Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.
Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic
FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma
Featured Press Releases
Rein Therapeutics announces the initiation of the RENEW Phase 2 trial of LTI-03 in patients with IPF
Genmab: Epcoritamab combo shows high response in R/R DLBCL patients eligible for ASCT
13 Jun 2025
Genmab A/S announced new results from the Phase 1b/2 EPCORE® NHL-2 trial Arm 10 (NCT04663347),
...
Marius Pharmaceuticals has expanded its global footprint with Health Canada’s approval of KYZATREX® (testosterone undecanoate) CIII capsules
Axion BioSystems Adds Affordable Maestro Volt™ to its Industry-Leading MEA System Lineup
Menarini Group Shares New Data on ELZONRIS® (tagraxofusp-erzs)
IMFINZI plus neoadjuvant EV improved survival outcomes in muscle-invasive bladder cancer in the Phase III VOLGA trial
Packaging Compliance Labs enters pharmaceutical testing market with dedicated lab and expert leadership
By
Packaging Compliance Labs
Packaging Compliance Labs
30 Sep 2026
Ro and Novo announce research collaboration to generate first-of-its-kind real-world evidence on the Wegovy® pill
By
Ro
Ro
30 Sep 2026
Cresilon launched next-generation TRAUMAGEL.
By
Cresilon
Cresilon
29 Sep 2026
SHARx Focuses on Rx Continuity for Employers and Patients as Customs Requirements Change
By
SHARx
SHARx
28 Sep 2026
Zifo Unveils Vision for an AI-Driven Scientific Semantic Layer in Biopharma
By
Zifo
Zifo
28 Sep 2026
ImmunoScape Appoints Peter Olagunju as Chief Executive Officer
By
ImmunoScape Pte. Ltd.
ImmunoScape Pte. Ltd.
23 Sep 2026
Log in
Username
Show
Remember Me
Log in
Create an account
Forgot your username?
Forgot your password?
Most Popular
Gvoke VialDx™ (glucagon injection) Launched by American Regent
By
American Regent, Inc
Aug 27
Genentech to Reintroduce Susvimo for Wet Age-related Macular Degeneration (AMD) Treatment
By
Genentech
Jul 08
Abbott Launched the First and Only Ready-to-Feed Liquid Infant Formula Made with Whole Milk in the U.S. at a Price Similar to Its Existing Similac Powdered Formula
By
Abbott
Sep 01
October
2026
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
User Area
Login page
Registration
Edit Profile
Forgot Password
Discover
About Us
Terms Of Use
Privacy Policy
FAQs
Engage with Us
Search on Site
Post Press Release
Promote Brand
List Your Event
Subscribe to Our Monthly Newsletter
Subscribe to Pharmaceutical Era’s monthly newsletter,
Pharmaceutical Leaders Digest
®, to receive timely updates from across the pharmaceutical industry.
I agree with the
Terms and conditions
×
and the
Privacy policy
×
Please enable the javascript to submit this form
Subscribe
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. To find out more, please click
here
.
I understand